NutriBand (NTRB) Cash & Current Investments (2016 - 2026)
NutriBand (NTRB) posted Cash & Current Investments of $4.0 million for Q2 2026, down 12.43% sequentially from $4.6 million in Q1 2026, and up 35.16% YoY from $3.0 million in Q2 2025.
NutriBand (NTRB) Cash & Current Investments (2016 - 2026) Analysis & Trends
NutriBand has reported Cash & Current Investments for 11 years, with the latest figure at $4.0 million in Q2 2026.
- Quarterly Cash & Current Investments rose 35.16% year-over-year to $4.0 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $4.0 million (up 35.16% YoY) and the FY2026 annual result came in at $4.6 million, up 6.1% from the prior year.
- Cash & Current Investments slipped to $4.0 million in Q2 2026 per NTRB's latest filing, from $4.6 million in the prior quarter.
- Over five years, Cash & Current Investments peaked at $8.3 million in Q2 2024 and troughed at $492942.0 in Q1 2024.
- A 5-year average of $4.0 million and a median of $4.0 million in 2022 frame the typical range for Cash & Current Investments.
- The sharpest annual moves came in 2022 and 2024: Cash & Current Investments surged 3118.48% in 2022, then plunged 75.17% in 2024.
- Over 5 years, Cash & Current Investments stood at $2.8 million in 2022, then tumbled by 55.07% to $1.3 million in 2023, then soared by 350.33% to $5.7 million in 2024, then decreased by 6.77% to $5.3 million in 2025, then retreated by 24.58% to $4.0 million in 2026.
- According to Business Quant data, Cash & Current Investments over the past three periods registered $4.0 million, $4.6 million, and $5.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 7.99 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 5.18 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.14 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 3.31 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 18.39 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.16 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 836.99 Mn |
| 10 | NutriBand | 57.74 Mn | 53.73 Mn | 196,801.00 | 4.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 4.01 Mn |
| Jan 31, 2026 | 4.57 Mn |
| Oct 31, 2025 | 5.31 Mn |
| Jul 31, 2025 | 7.00 Mn |
| Apr 30, 2025 | 2.96 Mn |
| Jan 31, 2025 | 4.31 Mn |
| Oct 31, 2024 | 5.70 Mn |
| Jul 31, 2024 | 6.76 Mn |
| Apr 30, 2024 | 8.35 Mn |
| Jan 31, 2024 | 492,942.00 |
| Oct 31, 2023 | 1.27 Mn |
| Jul 31, 2023 | 2.33 Mn |
| Apr 30, 2023 | 1.28 Mn |
| Jan 31, 2023 | 1.99 Mn |
| Oct 31, 2022 | 2.82 Mn |
| Jul 31, 2022 | 3.34 Mn |
| Apr 30, 2022 | 4.01 Mn |
| Jan 31, 2022 | 4.89 Mn |
| Oct 31, 2021 | 5.49 Mn |
| Jul 31, 2021 | 304,258.00 |